| Page | Hits | Percent |
|---|
|
| 665 |
50,76% |
| /programmes.html
| 127 |
9,69% |
| /lilly/fellowships/efsd-lilly-fship08.html
| 121 |
9,24% |
| /pfizer/efsd-pfizer-rfa08.html
| 26 |
1,98% |
| /amylin/efsd-amylin-rfa08.html
| 26 |
1,98% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa08.html
| 18 |
1,37% |
| /msd/albert-renold/efsd-msd-arenold.html
| 18 |
1,37% |
| /lifescan/efsd-lifescan-rfa08.html
| 16 |
1,22% |
| /lilly/programme/efsd-lilly-rfa08.html
| 15 |
1,15% |
| /novo-t2/efsd-novo-t2-rfa08.html
| 15 |
1,15% |
| /sanofi-aventis/endocannabinoid/efsd-sanofi-aventis-ecs-rfa08.html
| 14 |
1,07% |